Sort   by:  
 Page size 
ProteomicsGlobal analysis of cancer cell responses to USP9X inhibition
K-GG ubiquitin profiling of UO-31 cells treated with the selective USP9X inhibitor WEHI-092 at 10 µM for 30 min, 6 h, and 24 h (and DMSO-treated control). Sample IDs:#1-5 Control 30 min UO-31#6-10 WEHI-092 30 min UO-31#11-15 Control 360 min UO-31#16-20 WEHI-092 360 min UO-31#21-25 Control 24 h UO-31...
ORGANISM(S): Homo sapiens (Human) 
2026-04-09 | PXD073754 | Pride
ProteomicsGlobal analysis of cancer cell responses to USP9X inhibition
K-GG ubiquitin profiling of DLD-1 and MDA-MB-231 cells treated with the selective USP9X inhibitor WEHI-092 at 10 µM for 30 min, 6 h, and 24 h (and DMSO-treated control). This dataset also includes DLD-1 cells treated with FT671 (USP7 inhibitor) at 10 µM for 30 min and 6 h.Sample IDs:#1-5 Control 30 ...
ORGANISM(S): Homo sapiens (Human) 
2026-04-09 | PXD073869 | Pride
ProteomicsGlobal analysis of cancer cell responses to USP9X inhibition
K-GG ubiquitin profiling of SK-MEL-2 and UO-31 cells treated with the selective USP9X inhibitor WEHI-092 at 10 µM for 30 min, 6 h, and 24 h (and DMSO-treated control). This dataset is the matched global quantitative proteomics data.Sample IDs:#1-5 Control 30 min UO-31#6-10 WEHI-092 30 min UO-31#11-1...
ORGANISM(S): Homo sapiens (Human) 
2026-04-09 | PXD073798 | Pride
ProteomicsGlobal analysis of cancer cell responses to USP9X inhibition
Global proteomics experiment using USP9X siRNA (and control) MDA-MB-231 cells with (10 µM, 24 h) and without USP9X inhibitor treatment using WEHI-092 and untreated (DMSO) control (P5448, see sample key). Global proteomics experiment profiling cancer cell lines treated with USP9X inhibitor WEHI-092 (...
ORGANISM(S): Homo sapiens (Human) 
2026-04-09 | PXD062674 | Pride
UnknownA microneedle vaccine printer for thermostable COVID-19 mRNA vaccines.
Not available
S-EPMC10593912 | biostudies-literature
UnknownA multi-layered and dynamic apical extracellular matrix shapes the vulva lumen in Caenorhabditis elegans.
Not available
S-EPMC7544507 | biostudies-literature
UnknownRecurrent dominant mutations affecting two adjacent residues in the motor domain of the monomeric kinesin KIF22 result in skeletal dysplasia and joint laxity.
Not available
S-EPMC3234368 | biostudies-literature
ProteomicsGlobal analysis of cancer cell responses to USP9X inhibition
HDX-MS experiment using selective USP9X inhibitors WEHI-092, FT709 with recombinant catalytic domain USP9X.
ORGANISM(S): Homo sapiens (Human) 
2026-04-09 | PXD062754 | Pride
UnknownC9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation.
Not available
S-EPMC8298293 | biostudies-literature
UnknownImpact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study.
Not available
S-EPMC12451838 | biostudies-literature
Sort   by:  
 Page size